Crews Bank & Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-700
Closed -$18.5K 668
2026
Q1
$18.5K Hold
700
﹤0.01% 481
2025
Q4
$20.3K Hold
700
﹤0.01% 461
2025
Q3
$19.4K Hold
700
﹤0.01% 471
2025
Q2
$17K Hold
700
﹤0.01% 475
2025
Q1
$14.5K Hold
700
﹤0.01% 478
2024
Q4
$16.5K Buy
+700
New +$17.2K ﹤0.01% 465

Other funds holding ARKG

Crews Bank & Trust's ARKG Position: Q2 2026 in Review

Crews Bank & Trust sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 700 shares — an estimated $18.5K sold.

Crews Bank & Trust first reported a position in ARKG in Q4 2024 and held it in 6 quarters. The position peaked at $20.3K in Q4 2025. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Crews Bank & Trust reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
  • Crews Bank & Trust sold 700 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $18.5K.
  • Crews Bank & Trust first reported a position in ARK Genomic Revolution ETF in Q4 2024 and held it in 6 quarters.
  • Crews Bank & Trust's ARK Genomic Revolution ETF position peaked at $20.3K in Q4 2025.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Crews Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.